ROBINSON JAMES GEORGE purchased 0.3% of their position (9K shares) of NYMOX PHARMACEUTICAL CORP on the open market
Open‑market purchase worth $12.3K — a small addition. The strongest form of insider conviction signal.
Common Stock
Shares
+2.20K
Price / share
$1.36
Trade value
$3K
% of position
Common Stock
Shares
+4.81K
Price / share
$1.37
Trade value
$6.58K
% of position
Common Stock
Shares
+800.00
Price / share
$1.36
Trade value
$1.09K
% of position
Common Stock
Shares
+295.00
Price / share
$1.37
Trade value
$403.77
% of position
Common Stock
Shares
+28.00
Price / share
$1.37
Trade value
$38.33
% of position
Common Stock
Shares
+100.00
Price / share
$1.37
Trade value
$136.88
% of position
Common Stock
Shares
+371.00
Price / share
$1.36
Trade value
$504.56
% of position
Common Stock
Shares
+400.00
Price / share
$1.36
Trade value
$544.96
% of position
Net shares
+9K
Net value
$12.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2019 | P · Purchase | +2.20K | $1.36 | $3K | 0.1% | 3.47M | 3.47M |
| Common Stock Direct | 7/1/2019 | P · Purchase | +4.81K | $1.37 | $6.58K | 0.1% | 3.47M | 3.48M |
| Common Stock Direct | 7/1/2019 | P · Purchase | +800.00 | $1.36 | $1.09K | 0.0% | 3.48M | 3.48M |
| Common Stock Direct | 7/1/2019 | P · Purchase | +295.00 | $1.37 | $403.77 | 0.0% | 3.48M | 3.48M |
| Common Stock Direct | 7/1/2019 | P · Purchase | +28.00 | $1.37 | $38.33 | 0.0% | 3.48M | 3.48M |
| Common Stock Direct | 7/1/2019 | P · Purchase | +100.00 | $1.37 | $136.88 | 0.0% | 3.48M | 3.48M |
| Common Stock Direct | 7/1/2019 | P · Purchase | +371.00 | $1.36 | $504.56 | 0.0% | 3.48M | 3.48M |
| Common Stock Direct | 7/1/2019 | P · Purchase | +400.00 | $1.36 | $544.96 | 0.0% | 3.48M | 3.48M |
| Total | +9K | $12.31K | ||||||